Q3 2025 Labcorp Holdings Inc Earnings Call Transcript
Key Points
- Labcorp Holdings Inc (LH) reported strong revenue growth of 9% year-over-year, reaching $3.6 billion.
- The company achieved a 19% increase in adjusted EPS, reflecting strong financial performance.
- Diagnostics revenue increased by 8.5%, driven by strong organic growth of 6%.
- Central Laboratories experienced robust growth of 10%, offsetting softness in early development.
- Labcorp Holdings Inc (LH) continues to expand its strategic partnerships and acquisitions, enhancing its market presence and service offerings.
- Early Development revenue was lower than expected due to delayed study starts, prompting site consolidation and divestitures.
- The company faces potential revenue and EPS impact from the PAMA legislation, with a projected $100 million impact in 2026.
- Currency fluctuations negatively impacted revenue growth, contributing to a 40-basis point reduction in guidance.
- The Biopharma Laboratory Services segment experienced a lower-than-expected book-to-bill ratio of 0.9 for the quarter.
- Labcorp Holdings Inc (LH) anticipates challenges in maintaining margin expansion in the Biopharma Laboratory Services segment due to tougher year-over-year comparisons.
Good day, and thank you for standing by. Welcome to the Q3 2025 Labcorp Holdings earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Christin O'Donnell, Vice President of Investor Relations. Please go ahead.
Thank you, operator. Good morning, and welcome to Labcorp's third quarter 2025 conference call. As detailed in today's press release, there will be a replay of this conference call available. With me today are Adam Schechter, Chairman and Chief Executive Officer; and Julia Wang, Executive Vice President and Chief Financial Officer.
This morning, in the Investor Relations section of our website at www.labcorp.com, we posted both our press release and an Investor Relations presentation with additional information on our business operations, which include a reconciliation of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
